Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Bergenbio ASA (BGBIO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.14 0.00    0.00%
10:25:15 - Closed. Currency in NOK ( Disclaimer )
Type:  Equity
Market:  Norway
ISIN:  NO0010650013 
S/N:  NO0010650013
  • Volume: 49,776,395
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 0.14 - 0.15
Bergenbio 0.14 0.00 0.00%

BGBIO Recent Sentiments

 
This page contains information on users’ sentiments for the Bergenbio ASA stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Apr 08, 2024 Gregory Minasidis   0.16 Apr 15, 2024 @ 0.17 -6.25%
Feb 21, 2024 Jakub Dąda   0.18 Mar 15, 2024 @ 0.17 -5.56%
Dec 15, 2023 Ahmad Khedr   0.25 Dec 18, 2023 @ 0.27 +8.00%
Dec 12, 2023 Sigve Storksen   0.23 Jan 05, 2024 @ 0.33 -43.48%
Dec 12, 2023 Nabil Saleh   0.22 Dec 13, 2023 @ 0.23 +4.55%
Oct 30, 2023 Jakub Dąda   0.21 Nov 30, 2023 @ 0.15 -28.57%
Aug 28, 2023 Erik Amundsen   0.12 Nov 30, 2023 @ 0.15 +25.00%
Aug 03, 2023 Jan Erik Muri   0.11 Nov 30, 2023 @ 0.15 +36.36%
May 23, 2023 Sean Owens   0.49 Nov 30, 2023 @ 0.15 +69.39%
Oct 28, 2022 Inger Tveito   8.29 Nov 18, 2022 @ 7.47 -9.89%
Jun 08, 2022 Ida Gilbert   12.29 Jul 01, 2022 @ 12.15 -1.14%
May 11, 2022 Sigve Storksen   15.00 Jun 03, 2022 @ 13.90 -7.33%
Jan 06, 2022 Tommy Berg   20.00 Jan 19, 2022 @ 19.90 -0.50%
Oct 28, 2021 Artur Arakelian   19.12 Nov 19, 2021 @ 19.32 +1.05%
Sep 29, 2021 Sean Owens   21.00 Oct 22, 2021 @ 19.65 +6.43%
May 25, 2021 Ida Gilbert   22.72 Jun 18, 2021 @ 23.98 +5.55%
May 25, 2021 Sean Owens   22.80 Jun 18, 2021 @ 23.98 +5.18%
Apr 29, 2021 Daniel Berstad   28.84 May 03, 2021 @ 28.62 +0.76%
Apr 19, 2021 Ørjan Hesjedal   30.04 Apr 26, 2021 @ 29.70 -1.13%
Apr 19, 2021 Ryan He   30.20 Apr 26, 2021 @ 29.70 -1.66%
Apr 09, 2021 Ida Gilbert   33.56 Apr 30, 2021 @ 28.52 -15.02%
Apr 07, 2021 Ørjan Hesjedal   30.68 Apr 12, 2021 @ 31.50 +2.67%
Mar 02, 2021 Ryan He   30.40 Mar 26, 2021 @ 31.10 +2.30%
Feb 09, 2021 Tommy Berg   35.15 Mar 05, 2021 @ 30.45 -13.37%
Jan 19, 2021 Ryan He   36.65 Feb 12, 2021 @ 33.35 -9.00%
Jan 18, 2021 Rashmi Naik   35.60 Feb 12, 2021 @ 33.35 +6.32%
Dec 29, 2020 Rodrigo Sozo   32.50 Jan 22, 2021 @ 34.90 +7.38%
Dec 17, 2020 Sean Owens   34.40 Jan 08, 2021 @ 32.70 -4.94%
Nov 30, 2020 Tor Odd Silset   32.75 Dec 25, 2020 @ 33.40 +1.98%
Nov 27, 2020 Ryan He   31.80 Dec 18, 2020 @ 34.60 +8.81%
Oct 26, 2020 Anders Rud   31.10 Nov 20, 2020 @ 27.70 -10.93%
Sep 14, 2020 ruben pereira   34.15 Oct 09, 2020 @ 30.10 +11.86%
Sep 03, 2020 Erlend Finstad   32.65 Sep 25, 2020 @ 29.70 -9.04%
Aug 31, 2020 Tore Slørdahl   32.70 Sep 25, 2020 @ 29.70 -9.17%
Jul 29, 2020 Joona Varis   29.80 Aug 21, 2020 @ 33.95 +13.93%
Jul 29, 2020 Ricardo Puin Penagos   28.50 Aug 21, 2020 @ 33.95 +19.12%
Jul 09, 2020 Norman Muldoon   40.65 Jul 31, 2020 @ 31.40 -22.76%
Jul 07, 2020 Janus Saito Madsen   41.40 Jul 31, 2020 @ 31.40 -24.15%
Jun 23, 2020 Jonathan Freifeldt   44.25 Jul 17, 2020 @ 37.80 -14.58%
Jun 11, 2020 Tami Halverson   35.85 Jul 03, 2020 @ 38.10 -6.28%
Jun 10, 2020 Piotr Kowalczyk   37.25 Jul 03, 2020 @ 38.10 +2.28%
Jun 09, 2020 Norman Muldoon   36.50 Jul 03, 2020 @ 38.10 +4.38%
May 19, 2020 Tor Odd Silset   41.85 Jun 12, 2020 @ 37.85 -9.56%
May 19, 2020 Tor Odd Silset   41.30 May 19, 2020 @ 40.95 +0.85%
May 14, 2020 Norman Muldoon   38.90 Jun 05, 2020 @ 37.65 -3.21%
May 07, 2020 Sean Owens   34.95 May 29, 2020 @ 39.35 +12.59%
May 04, 2020 Cedric Bist   44.37 May 07, 2020 @ 34.85 -21.46%
May 04, 2020 Hasan Çatal   43.72 May 29, 2020 @ 39.35 -10.00%
May 04, 2020 Sean Owens   44.77 May 05, 2020 @ 37.00 -17.36%
Dec 16, 2019 Antanas Hermansen   21.30 Jan 10, 2020 @ 22.60 +6.10%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BGBIO Comments

Write your thoughts about Bergenbio ASA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jakub Dąda
Jakub Dąda Mar 20, 2024 4:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good news! 🚀🚀🚀
Ryan Mowat
Ryan Mowat Dec 14, 2020 8:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Perhaps one of the most interesting and undervalued stocks out there. 10x your moneys in 2 years may not be unrealistic. 20x your moneys in 5 years? Do your wallet a favour and take a closer look at BerGenBio. Strong cash position. Tons of independent research supporting bemcentinib as a key player in cancer survival, fibrosis treatment and as an antiviral (against covid, dengue, ebola and others). Great safety profile and well tolerated. Strong support from several BigPharma companies and leading global medical communities. Ambitious pipeline and lots more to come. Gigantic economic potential as treatment for mild and severe fibrosis (lung, liver and kidney fibrosis).
Anders Rud
Anders Rud Oct 26, 2020 9:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this Stock is going down
Frank Pedersen
Frank Pedersen Sep 29, 2020 1:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$BERGENBIO, OSE now is again participating in the Accord study in UK with a cure of Covid19, in parallell it is also starting test i Sout Africa for own account, and start in India is just around the corner with Bemcentinib as a Corona cure. The stock is still low priced?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email